Panuron Injection (Pancuronium) | Used as Muscle Relaxant for Surgical Procedures and Anesthesia

Precautions

Use Only in Hospital Setting

• Panuron Injection contains pancuronium and should be administered only by trained healthcare professionals
• Not for self use or home administration

Requires Ventilatory Support

• Causes complete muscle relaxation including respiratory muscles
• Patient must be on assisted ventilation during use

Monitoring is Essential

• Continuous monitoring of vital signs such as heart rate, blood pressure, and oxygen levels is required
• Neuromuscular function should be closely observed

Caution in Medical Conditions

• Use carefully in patients with kidney, liver, or cardiovascular disorders
• Dose adjustment or close monitoring may be needed

Drug Sensitivity and Allergy

• Inform healthcare provider about any known allergies to muscle relaxants
• Immediate medical support should be available in case of reaction

Use in Pregnancy and Special Populations

• Use only if clearly necessary and under strict medical supervision
• Extra caution required in elderly and critically ill patients

Usage

Dosage & Administration

• Strict Adherence: Panuron Injection must be administered strictly by qualified healthcare professionals (anesthesiologists or intensivists) in a clinical environment. Do not attempt to administer or use this medication outside of a hospital setting.

• Intravenous Administration: This medication is administered via the intravenous (IV) route only. The dosage is highly individualized, calculated by the clinician based on the patient's body weight, physical condition, and the specific requirements of the surgical or medical procedure.

• Airway Control: It is commonly used to facilitate endotracheal intubation by relaxing the muscles of the jaw and throat, allowing for the safe placement of a breathing tube.

• Maintenance: During lengthy surgical procedures, clinicians may administer additional, carefully monitored doses to maintain the required level of muscle relaxation.

Safety Precautions

• Essential Support: The use of Panuron is only appropriate in settings where full capabilities for mechanical ventilation and emergency airway management are immediately available.

• Sedation Requirement: Panuron causes paralysis but provides no sedation or pain relief. Patients must always receive adequate anesthesia or sedation concurrently to ensure they are unconscious and comfortable.

• Continuous Monitoring: Vital signs (heart rate, blood pressure, oxygen saturation) and neuromuscular transmission (using nerve stimulators) must be monitored continuously throughout the duration of the drug’s action.

• Storage: Panuron is a temperature-sensitive medication. It must be stored in a refrigerator at 2°C to 8°C. Do not freeze the product.

Treatment Administration Summary

Uses

• Surgical Relaxation: Used to induce profound skeletal muscle relaxation required for major surgeries, particularly abdominal, thoracic, or orthopedic procedures.

• Mechanical Ventilation Support: Used in Intensive Care Units (ICU) to assist patients who are struggling to "breathe with the ventilator," ensuring proper synchronization and effective oxygenation.

• Intubation: Facilitates safe endotracheal intubation by suppressing natural muscle reflexes that would otherwise interfere with the placement of airway devices.

Side Effects

Common Effects (Related to Intended Action)

• Muscle paralysis (including respiratory muscles, requiring ventilatory support)
• Temporary loss of voluntary movement

Cardiovascular Effects

• Increased heart rate (tachycardia)
• Mild increase in blood pressure in some cases

Respiratory Effects

• Prolonged respiratory muscle weakness after discontinuation
• Difficulty in spontaneous breathing until drug wears off

Gastrointestinal and General Effects

• Rare reduction in bowel movement due to reduced muscle activity
• Generalized weakness during recovery phase

Serious but Rare Effects

• Severe allergic reactions (rash, swelling, anaphylaxis)
• Prolonged neuromuscular blockade leading to extended ventilation requirement
• Irregular heart rhythm in sensitive patients

FAQs

Q: What is the primary purpose of Panuron?

A: Panuron is used in clinical settings to provide deep skeletal muscle relaxation. This is essential for successful endotracheal intubation and for maintaining stillness during major surgical procedures.

Q: Does Panuron make a patient unconscious?

A: No, it does not. Panuron is strictly a paralyzing agent and does not affect a patient's level of consciousness or their ability to feel pain. It must always be used in conjunction with appropriate sedatives and painkillers.

Q: Why is mechanical ventilation necessary when using this drug?

A: Panuron paralyzes all skeletal muscles, including the diaphragm and those responsible for breathing. Therefore, the patient must be connected to a ventilator to ensure they continue to breathe throughout the procedure.

Q: Who is authorized to administer Panuron?

A: Only healthcare professionals with specialized training in anesthesia and airway management should administer this drug. It is strictly used in controlled environments like operating rooms or intensive care units.

Q: How is the effect of the drug monitored?

A: Clinicians use a peripheral nerve stimulator to assess how much the muscles are responding. This helps them determine the exact level of blockade and when it is safe to begin or end a procedure.

Q: Can the paralysis be stopped quickly if needed?

A: The effects can be actively reversed using specific medications like neostigmine. These reversal agents allow the muscles to regain function once the surgical need for relaxation has passed.

Q: Does Panuron affect the heart rate?

A: It can cause a modest increase in heart rate and blood pressure in some patients. Medical staff monitor cardiovascular vitals constantly to manage these changes during the administration.

Q: Are there specific patients who should avoid Panuron?

A: Patients with severe kidney or liver impairment may require dose adjustments, as these organs are responsible for clearing the drug from the body. It is also avoided in patients with a known hypersensitivity to pancuronium bromide.

Q: How is the medication stored in a medical facility?

A: Panuron is a temperature-sensitive product. It must be stored in a refrigerator between 2°C and 8°C to maintain its potency and safety profile.

Q: What are the signs of a successful recovery from the drug?

A: Recovery is indicated by the return of muscle strength, such as the patient’s ability to lift their head, breathe deeply on their own, and maintain a firm grip.

Interactions

Other Muscle Relaxants and Anesthetic Agents

• Use with other neuromuscular blocking agents may enhance or prolong muscle paralysis
• Dosage adjustment and close monitoring are required

Inhalational and IV Anesthetics

• Certain anesthetic drugs may potentiate the effect of pancuronium
• Can increase duration of muscle relaxation

Antibiotics (Aminoglycosides)

• Drugs like gentamicin and amikacin may enhance neuromuscular blockade
• Increased risk of prolonged muscle weakness

Electrolyte Imbalances

• Low potassium or magnesium levels may intensify drug effect
• Correct electrolyte imbalance before administration

Other ICU Medications

• Drugs affecting heart rate or blood pressure may interact and require monitoring
• Use only in controlled hospital settings